More on EGRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.14 |
|
|||
| Open | $2.14 | ||||
| 52 Wk High | $102.48 | ||||
| 52 Wk Low | $33.02 | ||||
| Day High | $2.14 | ||||
| Day Low | $2.14 | ||||
| P/E | N/A | ||||
| EPS | $-1.02 | ||||
| Volume | 350 | ||||
- Eagle Pharmaceuticals Announces Divestiture of Barhemsys
- Eagle Pharmaceuticals (EGRX) Reports Q2 Loss of $0.12
- Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
- Eagle Pharmaceuticals appoints Abhinav Jain to board of directors
- Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
- Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
- Form SCHEDULE 13G EAGLE PHARMACEUTICALS, Filed by: J. Goldman & Co LP
- Form SCHEDULE 13G/A EAGLE PHARMACEUTICALS, Filed by: Nantahala Capital Management, LLC
Entities mentioned with EGRX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stock Buyback | View Related Stories »
- PDUFA | View Related Stories »
- JPMorgan | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
